Xenon Pharmaceuticals Reports 2Q 2023 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals Q2 Financial Results
On  August 09, 2023 , Xenon Pharmaceuticals (XENE) reported financial results for the second quarter ended June 30, 2023, and provided a corporate update.

Xenon report started with Mr. Ian Mortimer, the firm’s President and Chief Executive Officer, stating, “We are pleased to announce that patient enrollment is complete in our XEN1101 Phase 2 “X . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.